Cisatracurium Besylate
- Product NDC
- 24584-1111
- 11-digit product format
- 245841111
- Labeler code
- 24584
- Product ID
- 24584-1111_6c052e39-545c-4686-aa3e-d17ab471a50e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cisatracurium Besylate
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Piramal Healthcare UK Limited
- Application
- ANDA212432
- Marketing category
- ANDA
- Marketing start
- 2019-04-02
- Marketing end
- 0000-00-00
- Substance
- CISATRACURIUM BESYLATE
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 24584-1111 | CISATRACURIUM BESYLATE INJECTION [PIRAMAL HEALTHCARE UK LIMITED] | 4 | Legacy NDC | 20220326_2a68c2bc-3875-4782-820c-7dcad545ba9b.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 24584-1111-1 | 24584111101 | 5 mL in 1 VIAL, SINGLE-DOSE (24584-1111-1) | 5 ml | 2019-04-02 | 0000-00-00 | No | No | Current |